From 1995, the UK experienced an increase in morbidity and mortality due to serogroup C meningococcal disease, predominantly owing to the introduction and spread of a hyperinvasive clone associated ...

Neisseria meningitidis serogroups A, B, C, W, X, and Y cause outbreaks of meningococcal disease. Quadrivalent conjugate vaccines targeting the A, C, W, and Y serogroups are available. A pentavalent ...

Clinicians should be alert for invasive serogroup Y meningococcal disease in at-risk populations and those with unusual symptoms amid the highest annual number of cases reported since 2014, according ...

Invasive meningococcal disease caused by Neisseria meningitidis is primarily associated with serogroups A, B, C, W, X, and Y and is characterised by its sudden, unpredictable nature and devastating ...

Please provide your email address to receive an email when new articles are posted on . The CDC’s Advisory Committee on Immunization Practices is developing new guidelines for state and local health ...

Please provide your email address to receive an email when new articles are posted on . The FDA today approved the recombinant vaccine, Bexsero, for prevention of Neisseria meningitidis serogroup B ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

"The key take-home message is that whether and how meningococcal B vaccines are being used vary widely across countries. It is also worth noting that protein-based MenB vaccines have not been approved ...

The U.S. Food and Drug Administration announced today the approval of Trumenba, the first vaccine licensed in the United States to prevent invasive meningococcal disease caused by Neisseria ...

The U.S. Food and Drug Administration today approved Bexsero, a vaccine to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age ...

The meningococcal vaccine protects you from four types of bacteria that cause meningococcal disease. This illness can cause meningitis, an infection of the lining around the brain or spinal cord. It ...

Effective vaccines provide direct protection to immunized individuals, but may also provide benefits to unvaccinated individuals by reducing transmission and thereby lowering the risk of infection.